Please login to the form below
NEW APPOINTMENTS AND PROMOTION SIGNAL EXPANSION OF CELLO HEALTH INSIGHT QUANTITATIVE RESEARCH TEAM
Healthcare market research agency Cello Health Insight has announced the appointment of a Senior Methodologist in its quantitative research ‘IQ’ team, reflecting growth in demand in this area across the firm’s range of healthcare and pharmaceutical clients.
At the same time, the IQ team has been bolstered with the
appointment of a new Research Executive, and the promotion of another member of
the team to Director level – part of what is described as “a major
strengthening” of Cello Health Insight’s European quantitative research
capacity.
Experienced data analytics professional Massimo Bufi has joined the organisation as Senior Methodologist at Director Level. Holder of a Masters in Statistics for Market Research, he was most recently at Ipsos MORI where he headed up a team of research analysts in the customer experience (loyalty) function. His technical experience includes marketing mix modelling, path modelling, conjoint analysis and linear modelling.
Meanwhile, Richard Kunzmann, who has been with Cello Health Insight since February 2012, has been promoted to Director within the IQ team. Richard has a growing reputation within the quantitative market research world, and was a speaker at the British Healthcare Business Intelligence Association (BHBIA) conference in May.
Lisa Rollins has also joined the team as Research Executive. She was most recently a senior research analyst at Kantar Health.
Commenting on the expansion of the IQ team, Group Director and Head of IQ Practice Gracie van Kemenade said, “Growing demand for our quantitative research services means that we have undertaken a major strengthening of our IQ team, both in terms of numbers and breadth of expertise.
![]()
“I am delighted that through recruitment and through internal
promotion, we have been able to do just that.
We continue to seek top-quality practitioners to join us, and we expect
to make further announcements about expansion of the team in the coming weeks
and months.”
- ends -
Cello Health Insight www.cellohealthinsight.com Formerly Insight Research Group, Cello Health Insight is the global marketing research arm of Cello Health, with offices in London, New York, Chicago and Switzerland. Cello Health was launched in March 2014, bringing together Cello Group’s health-orientated agencies to create a new offer for clients in the healthcare sector. Cello Health consists of three distinct capabilities:
For further media information, please contact: Andy Newman on +44 (0)1603 465636 or +44 (0)7739 847964, andy@newmanassociates.co.uk, or Helen Lawn on +44 (0)1892 525141 or +44 (0)7879 818247, helen@helenlawn.co.uk
Experienced data analytics professional Massimo Bufi has joined the organisation as Senior Methodologist at Director Level. Holder of a Masters in Statistics for Market Research, he was most recently at Ipsos MORI where he headed up a team of research analysts in the customer experience (loyalty) function. His technical experience includes marketing mix modelling, path modelling, conjoint analysis and linear modelling.
Meanwhile, Richard Kunzmann, who has been with Cello Health Insight since February 2012, has been promoted to Director within the IQ team. Richard has a growing reputation within the quantitative market research world, and was a speaker at the British Healthcare Business Intelligence Association (BHBIA) conference in May.
Lisa Rollins has also joined the team as Research Executive. She was most recently a senior research analyst at Kantar Health.
Commenting on the expansion of the IQ team, Group Director and Head of IQ Practice Gracie van Kemenade said, “Growing demand for our quantitative research services means that we have undertaken a major strengthening of our IQ team, both in terms of numbers and breadth of expertise.
- ends -
Cello Health Insight www.cellohealthinsight.com Formerly Insight Research Group, Cello Health Insight is the global marketing research arm of Cello Health, with offices in London, New York, Chicago and Switzerland. Cello Health was launched in March 2014, bringing together Cello Group’s health-orientated agencies to create a new offer for clients in the healthcare sector. Cello Health consists of three distinct capabilities:
- Cello Health Insight: global marketing research and customer insight
- Cello Health Consulting: strategic consultancy
- Cello Health Communications: evidence and engagement
For further media information, please contact: Andy Newman on +44 (0)1603 465636 or +44 (0)7739 847964, andy@newmanassociates.co.uk, or Helen Lawn on +44 (0)1892 525141 or +44 (0)7879 818247, helen@helenlawn.co.uk
Company Details
Cello Health
+44 (0)20 7812 8460
Address:
11-13 Charterhouse Buildings
London
EC1M 7AP
UK
Latest content on this profile
- Cello Health Acquire ISS
- Acquisition further strengthens technical advisory services in US
Cello Health
- Cello Health launches ‘Cello Health GmbH’ with new Berlin office and appointment of two regional directors to lead the Business Insights and Analytics division in Germany.
- London, July 08, 2019 Cello Health GmbH opens in Berlin with its Business Insights and Analytics division, Cello Health Insight, appointing two regional directors: Heike Tombrink – Regional Director, Head of Cello Health Insight Germany, and Matthias Heurich – Regional Director, supporting Digital Innovation.
Cello Health
- Cello Health Insight wins EphMRA’s 2019 Market Research Excellence Award for 'Business Impact through Innovation'
- Cello Health Insight in partnership with Janssen Pharmaceuticals has won EphMRA’s 2019 Market Research Excellence Award for 'Business Impact through Innovation'.
Cello Health
- Cello Health Launches New Social Insight & Analytics Business
- Cello Health Logic offers pharmaceutical companies the ability to make sense of healthcare social media conversations and deliver actionable insights.
Cello Health
- Managing value: Why early asset development and commercialization is important
- Realising the full value of your asset – clinically and commercially – means thinking beyond the pure scientific value, even at the very early stages of development.
Cello Health
- Optimising market research data in rare disease
- Helping to provide powerful insights into the burden of disease and the patient-caregiver experience.
Cello Health
